Alira Health

Alira Health

MD&M West 2024

February 6 - 8, 2024 | Anaheim, CA, US

We are pleased to share that we will be speaking at MD&M West 2024, one of the leading medical device trade shows in the US. Inspired by the life-saving solutions and innovations that companies all over the world push to evolve, MD&M West’s mission is to unify the international medical device community together to support the growth of their company objectives and push the boundaries of the medical field to save and improve lives across the globe.

Join our Coffee Talk session on Tuesday, February 6.*

Published on:
January 17, 2024

*Coffee Talk sessions only available to MD&M West attendees

About Our Coffee Talk

“Global Medtech CDMOs: Update on Supply Chain Drivers and M&A Trends”

Tuesday, February 6 | 9:45 AM – 10:30 AM | Room 212AB

This presentation will provide insights into global medtech contract manufacturing trends and the European supply chain. By comparing European market trends with US opportunities and reviewing M&A activity from 2023, we will shed light on the industry’s global performance. The presentation of the trends will be followed by a fireside chat panel with Graham O’Brien, VP, Global Planning, Sourcing and Logistics at Edwards Lifesciences, and Riccardo Butta, President, Americas at Stevanato Group, who will discuss global supply chain trends and address critical industry challenges expected in 2024.

This presentation will mark the release of the 2024 edition of our annual CDMO MedTech Report.

Our Speakers

Carlo Stimamiglio

Carlo Stimamiglio

Partner, Transaction Advisory Services Carlo has over 15 years of experience in deal making roles and a global track record of healthcare transactions. Carlo is a recognized author and opinion leader in the global pharmaceutical and medical device manufacturing markets, fields in which he regularly advises M&A deals. Carlo leads Alira Health’s global MedTech investment banking practice, supporting companies in the structuring and execution of financing, M&A and global licensing deals. Carlo holds a MS in Finance from the University of Verona and an MBA from IE Business School. He is an investment banking representative, holding FINRA Series 79 and 63 licenses.
Sofia Puzzi

Sofia Puzzi

Manager, Transaction Advisory Services Sofia focuses on MedTech M&A deals, capital raisings, and pharmaceutical licensing. She holds a MSc in Management from ESSEC Business School, in France, with a major in Strategic Consulting and Therapeutic Innovation and a BSc in Business Economics from Bocconi University, in Italy. She is an investment banking representative, holding FINRA Series 79 license.
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.